Background: The incidence of candidemia in severe COVID-19 patients (0.8–14%) is two- to ten-fold higher than in non-COVID-19 patients. Methods: This retrospective analysis aimed to analyse the incidence of bloodstream infections (BSI) due to Candida in a cohort of COVID-19 patients supported with ECMO. Results: Among 138 intubated and ventilated patients hospitalized for ≥10 days in the intensive care unit of a teaching hospital, 45 (32.6%) patients received ECMO support, while 93 patients (67.4%) did not meet ECMO criteria and were considered the control group. In the ECMO group, 16 episodes of candidaemia were observed, while only 13 in patients of the control group (36.0% vs. 14.0%, p-value 0.004). It was confirmed at the survival analysis (SHR: 2.86, 95% CI: 1.39–5.88) and at the multivariable analyses (aSHR: 3.91, 95% CI: 1.73–8.86). A higher candida score seemed to increase the hazard for candidemia occurrence (aSHR: 3.04, 95% CI: 2.09–4.42), while vasopressor therapy was negatively associated with the outcome (aSHR: 0.15, 95% CI: 0.05–0.43). Conclusions: This study confirms that the incidence of candidemia was significantly higher in critically ill COVID-19 patients supported with VV-ECMO than in critically ill COVID patients who did not meet criteria for VV-ECMO.

High incidence of Candidemia in critically Ill COVID-19 patients supported by veno-venous extracorporeal membrane oxygenation. A retrospective study / Alessandri, Francesco; Ceccarelli, Giancarlo; Migliara, Giuseppe; Baccolini, Valentina; Russo, Alessandro; Marzuillo, Carolina; Ceparano, Mariateresa; Giordano, Giovanni; Tozzi, Pierfrancesco; Galardo, Gioacchini; Raponi, Giammarco; Mastroianni, Claudio Maria; Venditti, Mario; Pugliese, Francesco; D'Ettorre, Gabriella. - In: JOURNAL OF FUNGI. - ISSN 2309-608X. - 9:1(2023), pp. 1-11. [10.3390/jof9010119]

High incidence of Candidemia in critically Ill COVID-19 patients supported by veno-venous extracorporeal membrane oxygenation. A retrospective study

Francesco Alessandri
;
Giancarlo Ceccarelli;Giuseppe Migliara;Valentina Baccolini;Carolina Marzuillo;Mariateresa Ceparano;Pierfrancesco Tozzi;Giammarco Raponi;Claudio Mastroianni;Mario Venditti;Francesco Pugliese;Gabriella d’Ettorre
2023

Abstract

Background: The incidence of candidemia in severe COVID-19 patients (0.8–14%) is two- to ten-fold higher than in non-COVID-19 patients. Methods: This retrospective analysis aimed to analyse the incidence of bloodstream infections (BSI) due to Candida in a cohort of COVID-19 patients supported with ECMO. Results: Among 138 intubated and ventilated patients hospitalized for ≥10 days in the intensive care unit of a teaching hospital, 45 (32.6%) patients received ECMO support, while 93 patients (67.4%) did not meet ECMO criteria and were considered the control group. In the ECMO group, 16 episodes of candidaemia were observed, while only 13 in patients of the control group (36.0% vs. 14.0%, p-value 0.004). It was confirmed at the survival analysis (SHR: 2.86, 95% CI: 1.39–5.88) and at the multivariable analyses (aSHR: 3.91, 95% CI: 1.73–8.86). A higher candida score seemed to increase the hazard for candidemia occurrence (aSHR: 3.04, 95% CI: 2.09–4.42), while vasopressor therapy was negatively associated with the outcome (aSHR: 0.15, 95% CI: 0.05–0.43). Conclusions: This study confirms that the incidence of candidemia was significantly higher in critically ill COVID-19 patients supported with VV-ECMO than in critically ill COVID patients who did not meet criteria for VV-ECMO.
2023
covid-19; candida; mycosis; veno-venous ecmo
01 Pubblicazione su rivista::01a Articolo in rivista
High incidence of Candidemia in critically Ill COVID-19 patients supported by veno-venous extracorporeal membrane oxygenation. A retrospective study / Alessandri, Francesco; Ceccarelli, Giancarlo; Migliara, Giuseppe; Baccolini, Valentina; Russo, Alessandro; Marzuillo, Carolina; Ceparano, Mariateresa; Giordano, Giovanni; Tozzi, Pierfrancesco; Galardo, Gioacchini; Raponi, Giammarco; Mastroianni, Claudio Maria; Venditti, Mario; Pugliese, Francesco; D'Ettorre, Gabriella. - In: JOURNAL OF FUNGI. - ISSN 2309-608X. - 9:1(2023), pp. 1-11. [10.3390/jof9010119]
File allegati a questo prodotto
File Dimensione Formato  
Alessandri_High-incidence_2023.pdf

accesso aperto

Tipologia: Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza: Creative commons
Dimensione 536.59 kB
Formato Adobe PDF
536.59 kB Adobe PDF

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/1665137
Citazioni
  • ???jsp.display-item.citation.pmc??? 6
  • Scopus 7
  • ???jsp.display-item.citation.isi??? 6
social impact